316 results on '"Tomiyama, Takami"'
Search Results
2. The microtubule-dynamin binding inhibitor peptide PHDP5 rescues spatial learning and memory deficits in Alzheimer’s disease model mice
3. Investigating the efficacy of nasal administration for delivering magnetic nanoparticles into the brain for magnetic particle imaging
4. Peripheral administration of nanomicelle-encapsulated anti-Aβ oligomer fragment antibody reduces various toxic Aβ species in the brain
5. Peripheral Aβ acts as a negative modulator of insulin secretion
6. New Value of Acorus tatarinowii/gramineus Leaves as a Dietary Source for Dementia Prevention
7. Proteomic analysis involved with synaptic plasticity improvement by GABAA receptor blockade in hippocampus of a mouse model of Alzheimer’s disease
8. Keto form of curcumin derivatives strongly binds to Aβ oligomers but not fibrils
9. New Value of Acorus tatarinowii / gramineus Leaves as a Dietary Source for Dementia Prevention.
10. Mutations in the β-amyloid precursor protein in familial Alzheimer’s disease increase Aβ oligomer production in cellular models
11. Intranasal rifampicin for Alzheimer's disease prevention
12. Hawaiian native herb Mamaki prevents dementia by ameliorating neuropathology and repairing neurons in four different mouse models of neurodegenerative diseases
13. Increased GADD34 in oligodendrocytes in Alzheimer’s disease
14. Neurodegenerative Disorder FTDP-17–Related Tau Intron 10 +16C→T Mutation Increases Tau Exon 10 Splicing and Causes Tauopathy in Transgenic Mice
15. Rearrangement of microtubule networks by tau bearing missense mutations
16. Decreased levels of PDI and P5 in oligodendrocytes in Alzheimerʼs disease
17. Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice
18. Proteomic analysis of the brain tissues from a transgenic mouse model of amyloid β oligomers
19. C9orf72 Hexanucleotide Repeat Expansion-Related Neuropathology Is Attenuated by Nasal Rifampicin in Mice
20. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice
21. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers
22. Nasal Rifampicin Halts the Progression of Tauopathy by Inhibiting Tau Oligomer Propagation in Alzheimer Brain Extract-Injected Mice
23. Synaptic plasticity improved by GABAA receptor blockade are based on the changed protein expression in hippocampus of a mouse model of Alzheimer‘s disease.
24. Development of a Human Monoclonal Antibody against Cytomegalovirus with the Aim of a Passive Immunotherapy
25. Antiviral Activities of a Human Monoclonal Antibody against Human Cytomegalovirus
26. Oligomer-Targeting Prevention of Neurodegenerative Dementia by Intranasal Rifampicin and Resveratrol Combination – A Preclinical Study in Model Mice
27. The E693Δ Mutation in Amyloid Precursor Protein Increases Intracellular Accumulation of Amyloid β Oligomers and Causes Endoplasmic Reticulum Stress-Induced Apoptosis in Cultured Cells
28. Nasal Rifampicin Improves Cognition in a Mouse Model of Dementia with Lewy Bodies by Reducing α-Synuclein Oligomers
29. Structure–activity relationship of chalcones and related derivatives as ligands for detecting of β-amyloid plaques in the brain
30. Fluorine-19 Magnetic Resonance Imaging for Detection of Amyloid β Oligomers Using a Keto Form of Curcumin Derivative in a Mouse Model of Alzheimer’s Disease
31. Preventive Effect of Dementia on the Extract of Alpinia Galanga (P14-016-19)
32. Heavy Tau Burden with Subtle Amyloid β Accumulation in the Cerebral Cortex and Cerebellum in a Case of Familial Alzheimer’s Disease with APP Osaka Mutation
33. APP Osaka Mutation in Familial Alzheimer’s Disease—Its Discovery, Phenotypes, and Mechanism of Recessive Inheritance
34. The Syntaxin 5 Isoforms Syx5 and Syx5L have Distinct Effects on the Processing of β-amyloid Precursor Protein
35. Oligomeric Amyloid β-Protein as a Therapeutic Target in Alzheimerʼs Disease: Its Significance Based on its Distinct Localization and the Occurrence of a Familial Variant Form
36. Syntaxin 5 interacts specifically with presenilin holoproteins and affects processing of βAPP in neuronal cells
37. A Novel Presenilin-1 Mutation (Leu85Pro) in Early-Onset Alzheimer Disease With Spastic Paraparesis
38. Amyloid Beta Peptide-Induced Cerebral Neuronal Loss Is Mediated By Caspase-3 In Vivo
39. Lack of amyloid plaque formation in the central nervous system of a patient with Werner syndrome
40. Dimerization of presenilin-1 in vivo: suggestion of novel regulatory mechanisms leading to higher order complexes
41. Mutation (D472Y) in the Type 3 Repeat Domain of Cartilage Oligomeric Matrix Protein Affects Its Early Vesicle Trafficking in Endoplasmic Reticulum and Induces Apoptosis
42. P3-072: QUANTITATIVE MEASUREMENT OF AMYLOID BETA OLIGOMER IN MOUSE BRAIN USING DOT BLOT ASSAY
43. Ectopic Expression Induces Abnormal Somatodendritic Distribution of Tau in the Mouse Brain
44. Antiviral Activities of a Human Monoclonal Antibody against Human Cytomegalovirus
45. Distinguishable effects of Presenilin-1 and APP717 mutations on amyloid plaque deposition
46. Generation and characterization of a human monoclonal antibody that neutralizes diverse HIV-1 isolates in vitro
47. Ectopic expression induces abnormal somatodendritic distribution of tau in the mouse brain
48. P2‐054: MOLECULAR IMAGING AND TREATMENT OF ALZHEIMER'S DISEASE BY DEVELOPING AMYLOID‐β OLIGOMER ANTIBODIES THAT CROSS THE BLOOD‐BRAIN BARRIER
49. Rivastigmine Improves Appetite by Increasing the Plasma Acyl/Des-Acyl Ghrelin Ratio and Cortisol in Alzheimer Disease
50. ＜Symposium IV＞Oligomeric Aβ is the sole culprit molecule to cause Alzheimer's disease?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.